EMMLF
Price:
$0.0137
Market Cap:
$75.60M
OKYO Pharma Limited, a preclinical biopharmaceutical company, engages in developing therapeutics for patients suffering from inflammatory eye diseases and ocular pain in the United Kingdom. Its lead product includes OK-101 for the treatment of dry eye disease. The company is also developing OK-201, a bovine adrenal medulla, lipidated-peptide preclinical analogue candidate for the treatment of neuropathic ocular pain. OKYO Pharma Limited was incorporated in 2007 and is headquartered in London, the United Kingdom.
Industry
Biotechnology
IPO Date
2020-10-09
Stock Exchange
OTC
Ticker
EMMLF
According to OKYO Pharma Limited’s latest financial reports and current stock price. The company's current ROE is 73.68%. This represents a change of 297.35% compared to the average of 18.54% of the last 4 quarters.
The mean historical ROE of OKYO Pharma Limited over the last ten years is 40.12%. The current 73.68% ROE has changed 83.62% with respect to the historical average. Over the past ten years (40 quarters), EMMLF's ROE was at its highest in in the September 2019 quarter at 559.53%. The ROE was at its lowest in in the March 2022 quarter at -195.29%.
Average
40.12%
Median
0%
Minimum
-1469.36%
Maximum
1.10%
Discovering the peaks and valleys of OKYO Pharma Limited ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual ROE = 1.10%
Minimum Annual Increase = 0%
Minimum Annual ROE = -1469.36%
| Year | ROE | Change |
|---|---|---|
| 2025 | 84.80% | -70.37% |
| 2024 | 286.17% | -55.73% |
| 2023 | 646.39% | -450.80% |
| 2022 | -184.26% | 192.24% |
| 2021 | -63.05% | -105.72% |
| 2020 | 1.10% | -175.07% |
| 2019 | -1469.36% | -Infinity% |
| 2018 | 0% | 0% |
| 2017 | 0% | -100.00% |
| 2016 | -2.56% | -89.48% |
The current ROE of OKYO Pharma Limited (EMMLF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
339.12%
5-year avg
154.01%
10-year avg
40.12%
OKYO Pharma Limited’s ROE is less than PharmChem, Inc. (45.90%), greater than Kadimastem Ltd (0.16%), greater than Sorrento Therapeutics, Inc. (-1904.94%), less than IBEX Technologies Inc. (33.34%), greater than OptiBiotix Health Plc (-2.27%), less than Organicell Regenerative Medicine, Inc. (219.09%), less than Rapid Dose Therapeutics Corp. (105.94%), less than Renalytix Plc (123.11%), less than American Hemp Ventures, Inc. (0%), greater than Malachite Innovations, Inc. (-82.10%),
| Company | ROE | Market cap |
|---|---|---|
| 45.90% | $21.95M | |
| 0.16% | $9.50M | |
| -1904.94% | $16.54M | |
| 33.34% | $25.27M | |
| -2.27% | $20.06M | |
| 219.09% | $19.97M | |
| 105.94% | $19.93M | |
| 123.11% | $22.55M | |
| 0% | $16.47M | |
| -82.10% | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like OKYO Pharma Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like OKYO Pharma Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is OKYO Pharma Limited's ROE?
How is the ROE calculated for OKYO Pharma Limited (EMMLF)?
What is the highest ROE for OKYO Pharma Limited (EMMLF)?
What is the 3-year average ROE for OKYO Pharma Limited (EMMLF)?
What is the 5-year average ROE for OKYO Pharma Limited (EMMLF)?
How does the current ROE for OKYO Pharma Limited (EMMLF) compare to its historical average?